Stock symbol: TSX: TOS
Outstanding shares: 47,863,402
QUEBEC, April 27 /CNW Telbec/ - TSO3 Inc. ("TSO3") (TSX: TOS) will hold
its fiscal 2008 annual meeting of shareholders on Thursday, April 30, 2009, at
9:30 a.m. in Montreal. For those who are unable to attend in person, a webcast
of the meeting and management presentation will be accessible from TSO3's
website at www.tso3.com.
On this occasion, Mr. Germain Carrière, Chairman of the Board of
Directors of TSO3, and Mr. Ric Rumble, Company's CEO, will provide an update
on the current situation, as well as on development projects.
What: TSO3's Annual Meeting of Shareholders
When: Thursday, April 30, 2009, at 9:30 a.m.
Where: McCord Museum
Théâtre J. Armand-Bombardier
690 Sherbrooke Street West
TSO3, founded in Québec City in 1998, specializes in the research and
development of innovative, high-performance medical instrument sterilization
technology with high commercial potential. The Company's first product, the
TSO3 STERIZONE(R) 125L Sterilizer, is designed for sterile processing centers
in the hospital environment.
The Company believes that its technology represents an advantageous
replacement solution to other low temperature sterilization processes
currently used in hospitals.
TSO3's STERIZONE(R) 125L Sterilizer is cleared for commercialization by
the US Food and Drug Administration and by Health Canada for sterilization of
metal and heat sensitive instruments and devices with diffusion-restricted
spaces, such as the hinged portion of haemostats, forceps and scissors and
rigid endoscopes having a single stainless steel lumen as small as 0.9 mm
internal diameter and 485 mm long is in commercialization phase for this first
product since 2006.
For more information about TSO3, visit the Company's Web site at
For further information:
For further information: Marc Boisjoli, Chief Financial Officer, (418)
651-0003, ext. 228, email@example.com; Frédéric Tremblay, (514) 658-8033,
firstname.lastname@example.org; Source: TSO3 Inc.